XENE
NASDAQ · Biotechnology
Xenon Pharmaceuticals Inc
$37.74
-1.45 (-3.70%)
Performance
1D
—
1W
+0.88%
1M
+3.65%
3M
-41.24%
6M
-32.34%
1Y
-1.46%
YTD
-15.17%
Open$39.26
Previous Close$39.19
Day High$39.35
Day Low$37.64
52W High$72.66
52W Low$33.38
Volume—
Avg Volume1.19M
Market Cap3.58B
P/E Ratio—
EPS$-4.74
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$44.01
Below
SMA 200
$52.33
Below
RSI (14)
74.9
Overbought
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
26 analysts
Price Target
-47.1% upside
Current
$37.74
$37.74
Target
$19.98
$19.98
$12.55
$19.98 avg
$22.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.32M | 10.06M | 1.14B |
| Net Income | -430,040,711 | -417,740,571 | -213,860,892 |
| Profit Margin | -4,612.1% | -4,381.5% | -18.8% |
| EBITDA | -460,643,892 | -472,327,789 | -248,558,556 |
| Free Cash Flow | — | — | -268,893,932 |
| Rev Growth | -7.4% | -7.4% | +15.1% |
| Debt/Equity | — | — | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |